Conjunctivitis, Allergic - Drug therapy
Research News and Information

Sunday, November 22, 2009

Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.

30 Jul 2009 PURPOSE: The effects of cyclosporine A eye drops on the early-phase reaction were investigated in a type-I allergic conjunctivitis model. METHODS: Mice were actively sensitized with ragweed (RW) absorbed on aluminium hydroxide gel and challenged ... Read more...

A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.

30 Jul 2009 PURPOSE: To evaluate the effectiveness and safety of a novel cyclosporine 0.1% aqueous ophthalmic solution in a large population with vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC). METHODS: A prospective observational ... Read more...

[0.05% cyclosporine a for treatment of chronic severe ocular surface disease.]

30 Jul 2009 OBJECTIVE: To evaluate the effects of topical cyclosporin A on severe and corticodependent chronic ocular surface disorders (OSD), in immune inflammatory disease. DESIGN: Experimental study, Centre hospitalier universitaire (CHU) Bretonneau, Tours, ... Read more...

Latest indexed articles for 'Conjunctivitis, Allergic - Drug therapy'

These are the very latest articles for this heading:

• Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. 30 Jul 2009
• A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. 30 Jul 2009
• [0.05% cyclosporine a for treatment of chronic severe ocular surface disease.] 30 Jul 2009
• The relationship of intranasal steroids to intraocular pressure. 29 Jun 2009
• Intranasal corticosteroids: do they improve ocular allergy? 29 Jun 2009
• Treating the ocular symptoms of seasonal allergic rhinitis with triamcinolone acetonide aqueous nasal spray. 29 Jun 2009
• Anaphylaxis with use of eye-drops containing benzalkonium chloride preservative. 20 Jun 2009
• [Pollen indicators] 30 May 2009
• [How to use steroid eye drops: proper use and pitfall] 30 May 2009
• [Therapeutic options in vernal keratoconjunctivitis] 30 May 2009
• Cataract surgical problem: June consultation #1. 30 May 2009
• The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment. 30 May 2009
• Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. 30 May 2009
• Clinical efficacy of a Ginkgo biloba extract in the topical treatment of allergic conjunctivitis. 29 Apr 2009
• Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms. 8 Mar 2009
• Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis? 27 Feb 2009
• [Inflammation of the conjunctiva] 27 Feb 2009
• Singulair-induced anaphylaxis? 27 Feb 2009
• Role of histamine H(4) receptor in allergic conjunctivitis in mice. 24 Feb 2009
• Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice. 18 Feb 2009

See a longer list of these articles.

Technical information about 'Conjunctivitis, Allergic'

Definition: Conjunctivitis due to hypersensitivity to various allergens.

Descriptor UI: D003233

Alternative terms: Conjunctivitis, Allergic; Conjunctivitis, Atopic; Atopic Conjunctivitides; Atopic Conjunctivitis; Conjunctivitides, Atopic; Allergic Conjunctivitis; Allergic Conjunctivitides; Conjunctivitides, Allergic; Conjunctivitis, Vernal; Conjunctivitides, Vernal; Vernal Conjunctivitides; Vernal Conjunctivitis; Keratoconjunctivitis, Vernal; Keratoconjunctivitides, Vernal; Vernal Keratoconjunctivitides; Vernal Keratoconjunctivitis; Conjunctivitis, Giant Papillary; Conjunctivitides, Giant Papillary; Giant Papillary Conjunctivitides; Giant Papillary Conjunctivitis; Papillary Conjunctivitides, Giant; Papillary Conjunctivitis, Giant;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C11.187.183.200; C20.543.480.200;

History Note: 86

Technical Notes: coord IM with etiol of the allergy (IM) if specified